# Boston Scientific Corporation (BSX) — Q3-2021 Earnings Results

**Report date:** 2021-10-27 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2021

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 1.33%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.41 | N/A | +3.27% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, no specific revenue guidance was provided.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on innovation and growth in key markets.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.33%, likely due to the lack of revenue details and guidance, which may have left investors uncertain about future performance. The cautious tone from management suggests they are focused on long-term growth despite current market challenges.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2021_